The FDA's refusal to review the biologics license application (BLA) for the mRNA-1010 vaccine is a major regulatory and quality setback. This delays a potential major revenue stream and creates urgent pressure to fix underlying issues in their data, manufacturing, or submission processes.
Filing excerpt
On February 10, 2026, Moderna, Inc. (the “Company”) issued a press release regarding the receipt of a Refusal-to-File letter from the U.S. Food and Drug Administration (the “FDA”) for its investigational seasonal influenza vaccine, mRNA-1010.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-8kqualityIssueGet every 8-K signal for Moderna and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Moderna this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/5386c1f3-8046-4bf3-8176-ae51749ea918 returns this record as JSON. POST /v1/companies/enrich returns every signal for modernatx.com.
{
"signal_id": "5386c1f3-8046-4bf3-8176-ae51749ea918",
"signal_type": "sec-8k",
"signal_subtype": "qualityIssue",
"detected_at": "2026-02-17T09:03:45.262+00:00",
"company": {
"name": "Moderna",
"domain": "modernatx.com"
},
"data": {
"detail": "The FDA's refusal to review the biologics license application (BLA) for the mRNA-1010 vaccine is a major regulatory and quality setback. This delays a potential major revenue stream and creates urgent pressure to fix underlying issues in their data, manufacturing, or submission processes.",
"metrics": {
"timeframe": "immediate"
},
"summary": "Moderna receives FDA Refusal-to-File letter for influenza vaccine mRNA-1010",
"excerpts": "On February 10, 2026, Moderna, Inc. (the “Company”) issued a press release regarding the receipt of a Refusal-to-File letter from the U.S. Food and Drug Administration (the “FDA”) for its investigational seasonal influenza vaccine, mRNA-1010.",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285226000012/mrna-20260203.htm",
"filing_date": "2026-02-10",
"filing_year": 2026,
"fiscal_year_end": "02/03",
"sales_relevance": "Quality management needed",
"signal_category": "operations"
}
}
curl https://signals.autobound.ai/v1/signals/5386c1f3-8046-4bf3-8176-ae51749ea918 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"modernatx.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.